Symbols / HKPD $0.62 +1.29%
HKPD Chart
About
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Pharmaceutical Retailers | Market Cap | 6.80M |
| Enterprise Value | 6.17M | Income | -27.06K | Sales | 20.31M |
| Book/sh | 0.45 | Cash/sh | 0.27 | Dividend Yield | — |
| Payout | 0.00% | Employees | 27 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.33 | P/B | 1.36 | P/C | — |
| EV/EBITDA | 23.18 | EV/Sales | 0.30 | Quick Ratio | 2.65 |
| Current Ratio | 2.99 | Debt/Eq | 47.59 | LT Debt/Eq | — |
| EPS (ttm) | -0.00 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -4.70% | Earnings | — | ROA | 1.32% |
| ROE | -0.58% | ROIC | — | Gross Margin | 11.89% |
| Oper. Margin | -9.05% | Profit Margin | -0.13% | Shs Outstand | 11.00M |
| Shs Float | 3.21M | Short Float | 0.13% | Short Ratio | 0.04 |
| Short Interest | — | 52W High | 2.76 | 52W Low | 0.60 |
| Beta | — | Avg Volume | 41.15K | Volume | 44.26K |
| Target Price | — | Recom | None | Prev Close | $0.61 |
| Price | $0.62 | Change | 1.29% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.62
Latest analyst target
3. DCF / Fair value
$3.54
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.62
Low
—
High
—
Mean
—
- Insiders Who Purchased US$6.90m Of Hong Kong Pharma Digital Technology Holdings Stock May Not Have Expected 19% Tumble - simplywall.st Wed, 03 Dec 2025 08
- How Is HKPD Stock Performing? - StocksToTrade ue, 26 Aug 2025 07
- Is Hong Kong Pharma Digital Technology Holdings Limited's (NASDAQ:HKPD) 36% ROE Better Than Average? - Yahoo Finance ue, 15 Apr 2025 07
- Cellyan Biotechnology Co Ltd (NASDAQ: HKPD) - Share Price - intelligentinvestor.com.au ue, 06 Jan 2026 01
- symbol__ Stock Quote Price and Forecast - CNN Fri, 24 Jan 2025 06
- HKPD - Cellyan Biotechnology Co Ltd Latest Stock News & Market Updates - Stock Titan hu, 16 Jan 2025 08
- HKPD Stock Surges Amid Promising Investor Confidence and Financial Trends - StocksToTrade Sun, 07 Sep 2025 07
- HKPD Stock Price and Chart — NASDAQ:HKPD - TradingView Wed, 15 Jan 2025 18
- HKPD IPO News - Pharma services provider Hong Kong Pharma Digital Technology prices US IPO at the $4 low end - renaissancecapital.com ue, 14 Jan 2025 08
- Hong Kong Pharma Digital Completes $5.6M Nasdaq IPO, Shares Trading as HKPD - Stock Titan hu, 16 Jan 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | -9.60K | -8.00K | -687.28 |
| TaxRateForCalcs | 0.17 | 0.13 | 0.02 |
| NormalizedEBITDA | 1.27M | 2.60M | 1.79M |
| TotalUnusualItems | -58.21K | -62.52K | -31.24K |
| TotalUnusualItemsExcludingGoodwill | -58.21K | -62.52K | -31.24K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -27.06K | 1.33M | 998.20K |
| ReconciledDepreciation | 1.07M | 925.58K | 714.59K |
| ReconciledCostOfRevenue | 17.90M | 13.13M | 9.82M |
| EBITDA | 1.21M | 2.53M | 1.76M |
| EBIT | 133.78K | 1.61M | 1.04M |
| NetInterestIncome | -95.93K | -82.29K | -23.02K |
| InterestExpense | 97.67K | 82.77K | 23.24K |
| InterestIncome | 1.74K | 474.00 | 219.00 |
| NormalizedIncome | 21.55K | 1.38M | 1.03M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -27.06K | 1.33M | 998.20K |
| TotalExpenses | 20.11M | 15.02M | 11.48M |
| TotalOperatingIncomeAsReported | 132.04K | 1.61M | 1.04M |
| DilutedAverageShares | 11.00M | 11.00M | |
| BasicAverageShares | 11.00M | 11.00M | |
| DilutedEPS | 0.12 | 0.09 | |
| BasicEPS | 0.12 | 0.09 | |
| DilutedNIAvailtoComStockholders | -27.06K | 1.33M | 998.20K |
| NetIncomeCommonStockholders | -27.06K | 1.33M | 998.20K |
| NetIncome | -27.06K | 1.33M | 998.20K |
| MinorityInterests | 0.00 | 0.00 | |
| NetIncomeIncludingNoncontrollingInterests | -27.06K | 1.33M | 998.20K |
| NetIncomeContinuousOperations | -27.06K | 1.33M | 998.20K |
| TaxProvision | 63.17K | 196.25K | 22.57K |
| PretaxIncome | 36.11K | 1.53M | 1.02M |
| OtherIncomeExpense | -68.73K | -64.99K | -33.28K |
| OtherNonOperatingIncomeExpenses | -10.52K | -2.47K | -2.04K |
| SpecialIncomeCharges | -7.53K | 708.00 | 0.00 |
| GainOnSaleOfPPE | -7.53K | -10.85K | 0.00 |
| GainOnSaleOfBusiness | 0.00 | 11.56K | 0.00 |
| GainOnSaleOfSecurity | -50.69K | -63.23K | -31.24K |
| NetNonOperatingInterestIncomeExpense | -95.93K | -82.29K | -23.02K |
| InterestExpenseNonOperating | 97.67K | 82.77K | 23.24K |
| InterestIncomeNonOperating | 1.74K | 474.00 | 219.00 |
| OperatingIncome | 200.77K | 1.67M | 1.08M |
| OperatingExpense | 2.21M | 1.89M | 1.66M |
| OtherOperatingExpenses | -1.47K | -4.04K | -96.23K |
| SellingGeneralAndAdministration | 2.22M | 1.89M | 1.76M |
| GrossProfit | 2.42M | 3.56M | 2.74M |
| CostOfRevenue | 17.90M | 13.13M | 9.82M |
| TotalRevenue | 20.31M | 16.69M | 12.56M |
| OperatingRevenue | 20.31M | 16.69M | 12.56M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| OrdinarySharesNumber | 11.00M | 11.00M | 11.00M |
| ShareIssued | 11.00M | 11.00M | 11.00M |
| NetDebt | 1.13M | 714.90K | |
| TotalDebt | 2.37M | 2.09M | 691.08K |
| TangibleBookValue | 4.89M | 4.22M | 581.21K |
| InvestedCapital | 6.87M | 5.59M | 764.46K |
| WorkingCapital | 5.81M | 4.63M | 198.40K |
| NetTangibleAssets | 4.89M | 4.22M | 581.21K |
| CapitalLeaseObligations | 499.51K | 752.34K | 511.86K |
| CommonStockEquity | 4.99M | 4.25M | 585.24K |
| TotalCapitalization | 6.49M | 5.37M | 702.10K |
| TotalEquityGrossMinorityInterest | 4.99M | 4.25M | 585.24K |
| StockholdersEquity | 4.99M | 4.25M | 585.24K |
| OtherEquityInterest | -300.00K | -6.84K | |
| GainsLossesNotAffectingRetainedEarnings | 10.82K | -4.86K | -4.34K |
| OtherEquityAdjustments | 10.82K | -4.86K | -4.34K |
| RetainedEarnings | 1.50M | 1.53M | 201.39K |
| AdditionalPaidInCapital | 3.46M | 3.02M | 388.19K |
| CapitalStock | 11.00K | 10.00K | 6.84K |
| CommonStock | 11.00K | 10.00K | 6.84K |
| TotalLiabilitiesNetMinorityInterest | 4.43M | 4.41M | 2.82M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.51M | 1.24M | 271.45K |
| LongTermDebtAndCapitalLeaseObligation | 1.51M | 1.24M | 271.45K |
| LongTermCapitalLeaseObligation | 6.41K | 117.84K | 154.59K |
| LongTermDebt | 1.50M | 1.12M | 116.86K |
| CurrentLiabilities | 2.92M | 3.18M | 2.55M |
| CurrentDeferredLiabilities | 124.51K | 191.07K | 268.03K |
| CurrentDeferredRevenue | 124.51K | 191.07K | 268.03K |
| CurrentDebtAndCapitalLeaseObligation | 864.66K | 849.70K | 419.62K |
| CurrentCapitalLeaseObligation | 493.10K | 634.50K | 357.27K |
| CurrentDebt | 371.56K | 215.20K | 62.35K |
| OtherCurrentBorrowings | 371.56K | 180.49K | 62.35K |
| LineOfCredit | 0.00 | 34.70K | 0.00 |
| PayablesAndAccruedExpenses | 1.93M | 2.14M | 1.86M |
| CurrentAccruedExpenses | 25.07K | 33.78K | 65.80K |
| Payables | 1.90M | 2.10M | 1.80M |
| OtherPayable | 68.89K | 59.27K | 82.61K |
| DuetoRelatedPartiesCurrent | 1.31K | 500.68K | 290.81K |
| TotalTaxPayable | 105.06K | 218.83K | 22.54K |
| AccountsPayable | 1.73M | 1.32M | 1.40M |
| TotalAssets | 9.42M | 8.67M | 3.41M |
| TotalNonCurrentAssets | 690.17K | 865.52K | 658.29K |
| GoodwillAndOtherIntangibleAssets | 96.44K | 31.82K | 4.03K |
| OtherIntangibleAssets | 96.44K | 31.82K | 4.03K |
| NetPPE | 593.73K | 833.69K | 654.26K |
| AccumulatedDepreciation | -141.84K | -87.55K | -49.21K |
| GrossPPE | 735.58K | 921.24K | 703.47K |
| Leases | 67.42K | 48.49K | 24.74K |
| OtherProperties | 650.43K | 855.14K | 599.73K |
| MachineryFurnitureEquipment | 17.72K | 17.61K | 79.00K |
| Properties | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 8.73M | 7.80M | 2.75M |
| CurrentDeferredAssets | 0.00 | 1.26M | 0.00 |
| RestrictedCash | 400.00 | 7.68K | 0.00 |
| PrepaidAssets | 447.91K | 1.26M | 302.56K |
| Inventory | 559.98K | 933.30K | 190.89K |
| InventoriesAdjustmentsAllowances | 0.00 | 0.00 | 0.00 |
| FinishedGoods | 519.14K | 879.42K | 124.93K |
| RawMaterials | 40.84K | 53.88K | 65.95K |
| Receivables | 4.71M | 3.72M | 1.73M |
| OtherReceivables | 236.36K | ||
| DuefromRelatedPartiesCurrent | 57.31K | 19.97K | 83.92K |
| AccountsReceivable | 4.66M | 3.70M | 1.65M |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | 0.00 | 0.00 |
| GrossAccountsReceivable | 4.66M | 3.70M | 1.65M |
| CashCashEquivalentsAndShortTermInvestments | 3.01M | 619.58K | 524.61K |
| OtherShortTermInvestments | 2.26M | 0.00 | |
| CashAndCashEquivalents | 748.72K | 619.58K | 524.61K |
| CashFinancial | 748.72K | 619.58K | 524.61K |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| FreeCashFlow | 414.23K | -482.35K | 1.61M |
| RepaymentOfDebt | -2.52M | -1.77M | -1.34M |
| IssuanceOfDebt | 1.59M | 2.14M | 189.21K |
| IssuanceOfCapitalStock | 4.30M | 509.50K | 0.00 |
| CapitalExpenditure | -154.99K | -88.02K | -117.70K |
| InterestPaidSupplementalData | 97.67K | 82.77K | 57.33K |
| IncomeTaxPaidSupplementalData | 294.83K | 0.00 | 0.00 |
| EndCashPosition | 749.12K | 627.26K | 524.61K |
| BeginningCashPosition | 627.26K | 524.61K | 84.98K |
| EffectOfExchangeRateChanges | 12.50K | 455.00 | 321.00 |
| ChangesInCash | 109.36K | 102.19K | 439.31K |
| FinancingCashFlow | 2.00M | 537.32K | -1.16M |
| CashFlowFromContinuingFinancingActivities | 2.00M | 537.32K | -1.16M |
| NetOtherFinancingCharges | -1.38M | -345.22K | |
| NetCommonStockIssuance | 4.30M | 509.50K | 0.00 |
| CommonStockIssuance | 4.30M | 509.50K | 0.00 |
| NetIssuancePaymentsOfDebt | -927.31K | 373.03K | -1.16M |
| NetLongTermDebtIssuance | -927.31K | 373.03K | -1.16M |
| LongTermDebtPayments | -2.52M | -1.77M | -1.34M |
| LongTermDebtIssuance | 1.59M | 2.14M | 189.21K |
| InvestingCashFlow | -2.45M | -40.80K | -132.09K |
| CashFlowFromContinuingInvestingActivities | -2.45M | -40.80K | -132.09K |
| NetOtherInvestingChanges | 13.99K | -14.39K | |
| NetInvestmentPurchaseAndSale | -2.30M | 0.00 | 0.00 |
| PurchaseOfInvestment | -2.30M | 0.00 | 0.00 |
| NetIntangiblesPurchaseAndSale | -85.07K | -35.28K | -3.06K |
| PurchaseOfIntangibles | -85.07K | -35.28K | -3.06K |
| NetPPEPurchaseAndSale | -69.92K | -19.51K | -114.64K |
| SaleOfPPE | 0.00 | 33.23K | 0.00 |
| PurchaseOfPPE | -69.92K | -52.74K | -114.64K |
| OperatingCashFlow | 569.21K | -394.33K | 1.73M |
| CashFlowFromContinuingOperatingActivities | 569.21K | -394.33K | 1.73M |
| ChangeInWorkingCapital | -520.25K | -2.65M | 14.30K |
| ChangeInOtherWorkingCapital | -163.46K | 93.60K | 337.53K |
| ChangeInPayablesAndAccruedExpense | 282.01K | 91.03K | 977.84K |
| ChangeInPayable | 282.01K | 91.03K | 977.84K |
| ChangeInAccountPayable | 396.88K | -105.22K | 955.27K |
| ChangeInTaxPayable | -114.87K | 196.25K | 22.57K |
| ChangeInIncomeTaxPayable | -114.87K | 196.25K | 22.57K |
| ChangeInPrepaidAssets | -180.42K | ||
| ChangeInInventory | 378.20K | -741.95K | -191.16K |
| ChangeInReceivables | -1.02M | -2.09M | -1.11M |
| ChangesInAccountReceivables | -918.79K | -2.05M | -929.51K |
| DepreciationAmortizationDepletion | 1.07M | 925.58K | 714.59K |
| DepreciationAndAmortization | 1.07M | 925.58K | 714.59K |
| Depreciation | 1.07M | 925.58K | 714.59K |
| OperatingGainsLosses | 43.15K | -708.00 | |
| GainLossOnInvestmentSecurities | 43.15K | ||
| GainLossOnSaleOfPPE | 0.00 | 10.85K | 0.00 |
| GainLossOnSaleOfBusiness | 0.00 | -11.56K | 0.00 |
| NetIncomeFromContinuingOperations | -27.06K | 1.33M | 998.20K |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for HKPD
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|